The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost
Six weeks after the US Food and Drug Administration (FDA) failed to meet its 90-day deadline to clarify which cannabinoids
US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all
According to recent analysis from the Congressional Research Service, cannabis businesses may not need to wait for rescheduling to challenge
The Food and Drug Administration’s (FDA) 90-day deadline to clarify which cannabinoids will be banned under the incoming, controversial intoxicating
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After
Two separate bipartisan cannabis reform bills that, if passed, would transform US cannabis regulation across the country.
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red
The US House Committee on Oversight and Government Reform is set to hold a hearing to examine the Food and
The US Drug Enforcement Administration (DEA) has formally requested that the Food and Drug Administration be ‘compelled’ by the court to give evidence at the upcoming cannabis rescheduling hearings.
The lack of progress and clarity on regulations surrounding industrial hemp in the US has seen forecasts for the market
The US Food and Drug Administration (FDA), alongside the Federal Trade Comission (FTC), has issued a further five ‘warning’ letters
The head of the US Food and Drug Administration (FDA), Robert Califf, told elected officials this week that he believes
The US Food and Drug Administration (FDA) has released a swathe of new details into the research it conducted into
In a significant move to address the challenges faced by the U.S. hemp industry, 28 non-profit organizations – representing every
We won’t spam you
